Episodes: 182
Frequency: Irregular
Rating: 4.7/5.0
Estimated listeners: 100 - 1,000
Gender skew: Neutral
Listener location: USA
YouTube: 449 subscribers
Instagram: 4.5k followers
Publicly listed emails
marisol@healthtree.org
Looking for the right person? Join Podseeker to find direct host and producer contacts and manage your podcast outreach.
Dr. Urvi Shah - Diet Myths Vs Facts And How Nutrition Impacts Outcomes In Multiple Myeloma.
Robert Orlowski, MD, PhD - 2026 Multiple Myeloma Research/treatment Landscape; CAR T, Bispecific Antibodies, Targeted Therapies, Risk Determination, Smoldering Myeloma Strategies, And Clinical Trials.
Paul Richardson, MD - Mid-year Myeloma Innovation Review; Immunotherapy Including CAR T, Bispecific/trispecific Antibodies, And Antibody Drug Conjugates.
Answering the Transplant Question for Newly Diagnosed Patients - The FASTER Study
October 12, 2026
For three decades, a stem cell transplant has been a standard part of care for newly diagnosed myeloma patients who are eligible for one. But with powerful immunotherapies moving earlier into treatment, a question patients ask us constantly is finally being put to the test: is transplant still necessary?Dr. Timothy Schmidt of the University of Wisconsin joins us to discuss FASTER, a COMMIT consortium trial he co-chairs. After induction therapy, FASTER randomly assigns patients to either a bis...
Inobrodib: A New Oral Myeloma Treatment with Dr. Nisha Joseph
August 28, 2026
A new oral myeloma treatment is now in development. It doesn't work like anything else in your treatment history and has activity in patients who've run out of options. Join us as Dr. Nisha Joseph of Emory's Winship Cancer Institute breaks down how Inobrodib works, who it might help, and where it fits in the future of myeloma care.
Myths vs. Facts about Diet in Multiple Myeloma
February 24, 2026
Listen to this episode where Dr. Urvi Shah will talk about the myths and facts about food and how our diet impacts our outcomes when it comes to our myeloma journey
The Cancer SIGNAL · Medium booking difficulty · 100 - 1,000 listeners
The Immunobuddies · Medium booking difficulty · 100 - 1,000 listeners
Its publicly listed email is marisol@healthtree.org. For guest bookings, the host or producer is usually the best person to reach. Podseeker helps you find direct host and producer contacts and pitch from your own inbox.
The publicly listed email for HealthTree Podcast for Multiple Myeloma: marisol@healthtree.org.
Podseeker estimates HealthTree Podcast for Multiple Myeloma reaches 100 to 1,000 listeners per episode. Only the publisher has exact numbers.
HealthTree Podcast for Multiple Myeloma typically books industry leaders. Typical guest background: Top multiple myeloma researchers and physician-scientists (often academic oncology centers) with established clinical/research roles and expertise in current myeloma innovation (e.g., immunotherapy, CAR T, bispecifics, clinical trials). Common among recent guests: Academic leadership at major cancer centers; Key contributions to myeloma clinical trials or treatment development; Scholarly publications and conference-level expertise. Recent guests include Dr. Urvi Shah, Robert Orlowski, MD, PhD, and Paul Richardson, MD.
High. It mostly books established leaders in its field.
Recent episodes cover Multiple Myeloma, Oncology, Hematology, Immunotherapy, and Clinical Trials. Pitch an idea tied to one of these topics and mention a recent episode.
Publicly listed emails
marisol@healthtree.org
Looking for the right person? Join Podseeker to find direct host and producer contacts and manage your podcast outreach.
Try us risk free with a FREE 3 days trial.
Join hundreds of PR teams using Podseeker to pitch and land bookings